[Drug therapy of various collagen diseases based on connective tissue metabolism--with special reference to systemic scleroderma].
D000328:Adult; D003238:Connective Tissue / Q000378:metabolism*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010396:Penicillamine / Q000627:therapeutic use; D010936:Plant Extracts / Q000627:therapeutic use; D011402:Pronase / Q000627:therapeutic use; D012595:Scleroderma, Systemic / Q000188:drug therapy* / Q000652:urine; D013974:Thyroxine / Q000627:therapeutic use; D014020:Tissue Extracts / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D010936:Plant Extracts; D014020:Tissue Extracts; D014568:Urokinase-Type Plasminogen Activator; D011402:Pronase; D010396:Penicillamine; D013974:Thyroxine